-
-
-
-
-
-
-
Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
-
-
-
-
-
-
-
Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer
-
-
-
-
-
-
-
OVID Provides Update on OV101 Program and the Prioritization of its Resources
-
-
-
-
-
-
-
Ovid Therapeutics (OVID), Takeda Pharmaceutical Co. Report Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint
-
-
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

